David James Wilber MD

Cardiology•Maywood, IL

Adult Congenital Heart Disease, Cardiac Electrophysiology

Professor of Medicine, Loyola University-Stritch School of Medicine

Join to View Full Profile

2160 S First AveMaywood, IL 60153
Phone+1 708-216-2642
Fax+1 708-327-2377

Education & Training

University of MichiganFellowship, Cardiovascular Disease, 1982 - 1984
McGaw Medical Center of Northwestern UniversityResidency, Internal Medicine, 1977 - 1980
Northwestern University The Feinberg School of MedicineClass of 1977

Certifications & Licensure

IL State Medical License 1978 - 2026
MI State Medical License 1982 - 1986
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Cardiovascular Disease

Awards, Honors, & Recognition

West Suburban Living Magazine Castle Connolly, 2014
America's Top Doctors Castle Connolly, 2002-2014
Chicago Magazine: Top Doctors Castle Connolly, 2004, 2006, 2008, 2010, 2012, 2014
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Super Doctor SuperDoctors.com
Fellow (FACC) American College of Cardiology
Join now to see all

Clinical Trials

NAVISTAR® THERMOCOOL® Catheter for the Radiofrequency Ablation of Symptomatic Paroxysmal Atrial Fibrillation Start of enrollment: 2004 Oct 01
Completed
Phase 3
NAVISTAR® THERMOCOOL® Catheter for the Radiofrequency Ablation of Symptomatic Paroxysmal Atrial Fibrillation- Treatment Use Study
TERMINATED
PHASE3
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial Start of enrollment: 2009 Nov 13
Completed
Not Applicable
THERMOCOOL® SMARTTOUCH™ Catheter for the Treatment of Symptomatic Paroxysmal Atrial Fibrillation
COMPLETED
PHASE3
Early Ablation Therapy for the Treatment of Ischemic Ventricular Tachycardia in Patients With Implantable Cardioverter Defibrillators Start of enrollment: 2012 Jun 01
Terminated
Phase 4
Early Elimination of Premature Ventricular Contractions in Heart Failure Start of enrollment: 2013 Jan 01
Terminated
Not Applicable
nMARQ™ Pulmonary Vein Isolation System for the Treatment of Paroxysmal Atrial Fibrillation Start of enrollment: 2013 Apr 01
TERMINATED
PHASE3
SERF VT Ablation Early Feasibility Study (EFS) Start of enrollment: 2018 Nov 01
Completed
Not Applicable
Join now to see all

Publications & Presentations

PubMed

Application of artificial intelligence to analyze data from randomized controlled trials: An example from DECAAF II.
Mario Mekhael, Han Feng, Nazem Akoum, Christian Sohns, Philipp Sommer
Heart Rhythm. 2025-01-13
Lesion delivery and scar formation in catheter ablation for atrial fibrillation: The DECAAF II trial.
Nazem Akoum, Mario Mekhael, Felipe Bisbal, Oussama Wazni, Christopher McGann
Heart Rhythm. 2024-09-06
Patient-Centered Rocket Science: Accurate but Imprecise.
Jeffrey A Bakal, David Wilber
Journal of the American Heart Association. 2024-06-04

Lectures

Best of JACC: Electrophysiology 2018
2019 ACC Scientific Session & Expo, New Orleans - 3/18/2019
Debate: ICD Implantation -EF Should Guide ICD Implantation?
2019 ACC Scientific Session & Expo, New Orleans - 3/17/2019
Year in Review Speaker
2019 ACC Scientific Session & Expo, New Orleans - 3/17/2019

Press Mentions

First-in-Human Trial Shows Promise for Hard-to-Treat Ventricular Tachycardia Heart RhythmsAugust 2nd, 2022
Late-Breaking Science Presentations at the AHA 2021 MeetingNovember 11th, 2021
AtriCure Announces Successful Completion of Patient Enrollment of aMAZE Clinical Trial and FDA Approval of Continued Access ProtocolJanuary 7th, 2020
Join now to see all

Professional Memberships

American College of Cardiology - ACC
Member